View on market: Stay Cautious, be with quality business:
Asian stocks were mixed and U.S. equity futures slipped Monday after a Federal Reserve official flagged the possibility of sharper interest-rate increases and Chinese data signaled slower economic growth. Shares rose in Japan and fluctuated in Australia, while S&P 500 and Nasdaq 100 contracts edged lower. China and South Korea are shut for the Lunar New Year holiday. Hong Kong’s session is truncated. The Singapore-traded SGX Nifty, an early indicator of India’s Nifty 50 Index’s performance, rose 0.83% to 17,234 as of 7:05 a.m. Crude oil climbed and gold extended a retreat. In the cryptocurrency sector, Bitcoin was steady at around $38,000. Pentagon Says Putin Still Adding Russian Troops Around Ukraine
Economic Calendar:
- INR: GDP Annual on 31st January, 2022.
- INR: Trade Balance on 2nd Febuary 2022.
- USD: OPEC Monthly Report on 2nd Febuary, 2022.
- USD: Manufacturing PMI on 1st February, 2022.
Earnings: Tata Motors Sun Pharmaceutical Industries IOCL BPCL HPCL UPL DLF Ajanta Pharma Exide Industries Edelweiss Financial Services Godawari Power & Ispat KPIT Technologies Hester Biosciences KEC International Shipping Corporation Of India UCO Bank Vinati Organics Aarti Drugs Navin Fluorine International Jindal Saw ADF Foods Infibeam Avenues Krsnaa Diagnostics Apar Industries Confidence Petroleum India LT Foods Dwarikesh Sugar Industries LG Balakrishnan & Bros Navneet Education Orient Cement Results:
L&T: Q3FY22 (Consolidated, YoY) Revenue from operations up 11.14% at Rs 39,562.92 crore Vs Rs 35,596.42 crore Profit after tax down 16.69% at Rs 2,055 crore Vs Rs 2,466.71 crore Ebitda down 5.85% at Rs 4,530.42 crore Vs Rs 4,279.95 crore Ebitda margin at 11.5% Vs 12.0%
Britannia: Q3FY22 (Consolidated, YoY) Revenue up 13% at Rs 3,574.98 crore Vs Rs 3,165.61 crore Net profit down 19% at Rs 371.18 crore Vs Rs 455.75 crore Ebitda down 12% at Rs 539.72 crore Vs Rs 611.52 crore Margin at 15.1% Vs 19.3%
Marico: Q3FY22 (Consolidated, YoY) Revenue up 13% at Rs 2,407 crore Vs Rs 2,122 crore (Bloomberg estimate: Rs 2,403.71 crore) Net profit up 1% at Rs 310 crore Vs Rs 307 crore Ebitda up 4% at Rs 431 crore Vs Rs 413 crore (Bloomberg estimate: Rs 421.51 crore) Margins at 17.9% Vs 19.5% (Bloomberg estimate: 17.5%).
United Breweries: Q3FY22 (Consolidated, YoY) Revenue up 15% at Rs 3,511.85 crore Vs Rs 3,065.89 crore Net profit down 28% at Rs 90.79 crore Vs Rs 126.78 crore Ebitda at Rs 174.17 crore Vs Rs 174.44 crore Margin at 5% Vs 5.7%.
Crompton Greaves Consumer Electricals: Q3FY22 (Consolidated, YoY) Revenue up 5% at Rs 1,410.59 crore Vs Rs 1,348.17 crore Net profit down 2% at Rs 148.26 crore Vs Rs 151.09 crore Ebitda up 1% at Rs 201.53 crore Vs Rs 200.05 crore Margin at 14.3% Vs 14.8%.
Brokerage Radar:
CLSA ON DRL: Buy, TP cut to Rs 5720 from Rs 6060 Q3 Revenue miss but margin beat Cut FY23-24 EPS est 5-8% as remove vaccine, gNuvaring & gCopaxone contributions, given uncertainty on these launches.
CITI ON VEDANTA: Buy, TP Raised to Rs 435 from Rs 400 Bullish Aluminium, Await Restructuring Contours Potential restructuring to unlock value, access to HZL cash (in case VED buys stake) should help alleviate group leverage concerns.
UBS ON KOTAK BANK: Sell, TP Rs 1975 Strong loan growth, stable asset quality Increase Opex est, reduce fee income & reduce credit cost est by 26bp/20bp for FY22/23 resulting in eps decline of 1.8%/0.4% Premium val of 3.9x FY23 P/BV seem to price in most +ves
International Markets:
U.S & Europe
| Particulars | 28th Jan | Chg | Chg(%) |
| Nasdaq | 13,770.57 | 417.79 | 3.13 |
| Dow | 34725.47 | 564.60 | 1.65 |
| FTSE | 7,466.07 | -88.24 | -1.17 |
| CAC | 6,965.88 | -57.92 | -0.82 |
| DAX | 15,318.95 | -205.32 | -1.32 |
| Dow Fut.* | 34753.7 | 28.2 | 0.08 |
Asian markets:
| Particulars | 31st Jan | Chg. | Chg(%) |
| SGX Nifty | 17,263.00 | 171 | 1 |
| Nikkei | 26,981.89 | 264.55 | 0.99 |
| Straits Times | 3,267.03 | 20.7 | 0.64 |
| Hang Seng | 23,721.10 | 171.02 | 0.73 |
| Shanghai | 3,361.44 | -32.81 | -0.97 |
ADR Watch:
| Particulars | 28nd Jan | Chg. | Chg.(%) |
| Dr Reddy | 55.95 | 0.62 | 1.12 |
| HDFC Bank | 65.46 | 0.68 | 1.05 |
| ICICI Bank | 21.02 | 0.14 | 0.67 |
| Infosys | 22.66 | 0.85 | 3.9 |
| Tata Motor | 32.77 | 0.07 | 0.21 |
| Wipro | 7.41 | 0.33 | 4.66 |
Commodities & Currency:
| Particulars | Current Price | Chg(%) |
| USD/INR | 75.04 | -0.04 |
| Brent | 89.54 | 0.46 |
| Gold | 1788.40 | 0.20 |
| Silver | 22.337 | 0.16 |
FIIs & DII
| Particulars | 28th Jan | 27th Jan |
| FIIs | -5045.34 | -6266.75 |
| DIIs | 3358.67 | 2881.32 |
News Update:
Zomato: To invest Rs 112.20 crore to acquire 19.48% stake in advertising technology company Adonmo. The company will also buy a 5% stake in software firm UrbanPiper Technology for Rs 37.38 crore. Zomato’s board has also approved setting up a fully-owned subsidiary for undertaking non-banking financial services.
Bharat Electronics: The company has declared interim dividend of Rs 1.5 per share. It has also approved increase in Authorised Capital of the company from existing Rs.250 crore to Rs.750 crore.
NCC: The company received NCLT approval for the scheme of arrangement for merger of Avathesh Property Developers and Bhuvanesh Realtors with Sirisha Projects.
Source: Moneycontrol, Livemint,, Bloomberg, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL